期刊文献+

获得性金属β-内酰胺酶初筛方法的研究 被引量:25

Methods Screening Acquired Metallo-β-lactamases
下载PDF
导出
摘要 目的 探讨并建立适用于临床微生物实验室常规初筛检测获得性金属 β 内酰胺酶 (MBL)的实验方法 ,为监控产酶株的流行及指导临床合理选择抗生素提供依据。方法 以EDTA和巯基乳酸 (TLA)为MBL的抑制剂 ,以亚胺培南 (IPM)和头孢他啶 (CAZ)为MBL的底物 ,采用纸片协同法和复合纸片法作MBL初筛试验 ,将几种初筛试验的结果与聚合酶链反应 (PCR)的结果进行比较分析。结果 应用PCR法 ,在 10 2株耐IPM和 (或 )CAZ铜绿假单胞菌中检出VIM型MBL阳性株 11株 ,其中 1株经DNA测序证实为VIM 2亚型 ;几种初筛试验中 ,IPM EDTA复合纸片法的阳性预测值 (90 9% )和阴性预测值 (98 9% )最高 ,敏感性 (90 9% )和特异性 (98 9% )都 >90 %。结论 IPM EDTA复合纸片法方法简便、结果可靠 。 OBJECTIVE To explore and establish a method for screening acquired metallo β lactamases (MBL) in clinical microbiology laboratory. METHODS Clinical isolates of Pseudomonas aeruginosa with a reduced susceptibility to imipenem (IPM) and/or ceftazidime (CAZ) were subjected to PCR analyses with primers specific to blaIMP and blaVIM. In addition, the double disk synergy test and the inhibitor potentiated disk diffusion test, using two kinds of substrate inhibitor combinations (ceftazidime thiolactic acid (CAZ TLA) and imipenem EDTA (IPM EDTA), were investigated and the results were evaluated with those of PCR analyses. RESULTS Among 102 test strains, 11 were positive in PCR analyses with blaVIM primers, and one of them had been identified as VIM 2 by DNA sequence. The inhibitor potentiated disk diffusion test using IPM EDTA showed high sensitivity (90 9%), specificity (98 9%) and predictive value (positive predictive value: 90 9%, negative predictive value: 98 9%). CONCLUSIONS The inhibitor potentiated disk diffusion test using IPM EDTA is a convenient and credible method for detecting acquired MBL producer in clinical microbiology laboratory.
出处 《中华医院感染学杂志》 CAS CSCD 2004年第6期603-606,共4页 Chinese Journal of Nosocomiology
基金 湖北省卫生厅重点资助项目 (WJ0 15 6 4 )
关键词 金属Β-内酰胺酶 药物敏感性试验 诊断试验 Metallo-β-lactamase Drug sensitivity tests Diagnostic tests
  • 相关文献

参考文献6

  • 1Lauretti L, Riccio ML, Mazzariol A, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate[J]. Antimicrob Agents Chemother, 1999, 43(7): 1584-1590.
  • 2Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France[J]. Antimicrob Agents Chemother, 2000, 44(4): 89
  • 3Lee K, Lim JB, Yum JH, et al. blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital[J]. Antimicrob Agents Chemother, 2002, 46(4): 1053-1058.
  • 4Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol, 2000, 3(5): 489-495.
  • 5Yan JJ, Hsueh PR, Ko WC, et al. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme[J]. Antimicrob Agents Chemother, 2001, 45(18): 2224-2228.
  • 6Concha NO, Janson CA, Rowling P, et al. Crystal structure of the IMP-1 metallo-β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor[J]. Biochemistry, 2000

同被引文献157

引证文献25

二级引证文献142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部